| Date | Ref. No. | Patent No. | Title |
| 1/11/2013 | E-264-2011/0 | | Virus-Like Particles Mediated Protein and RNA Delivery |
| 11/16/2012 | E-230-2012/0 | | A New Class, Now in Session: the First HLA Class II Restricted T Cell Receptor that Recognizes the Cancer Testis Antigen, MAGE-A3, Developed for Cancer Immunotherapy |
| 11/15/2012 | E-267-2012/0 | | A Novel Immortalized Human Adrenal Cell Line with Inactive Protein Kinase A for Studies on cAMP Signaling and Endocrine Tumorigenesis |
| 9/10/2012 | E-136-2012/0 | | High-Affinity Mouse Monoclonal Antibodies to Glypican-3 (GPC3) for Treatment of Cancer |
| 8/28/2012 | E-277-2001/0 | | Immunoglobulin-producing Mouse Plasmacytomas |
| 8/17/2012 | E-274-2008/0 | | Monoclonal Antibodies to the Tumor-Specific Antigen, Human ROR1 |
| 8/1/2012 | E-071-2007/0 | | Transgenic Mouse Model Useful for the Study of Myelodysplastic Syndrome |
| 7/31/2012 | E-261-2007/0 | | Mouse Embryonic Stem Cell-based Functional Assay to Evaluate Mutations in BRCA2 |
| 7/31/2012 | E-216-2009/0 | | High Diversity/High Affinity Domain Antibody Library |
| 5/24/2012 | E-177-2012/0 | | Rabbit Polyclonal Antibody to Detect a Pro-peptide Fragment of NSAID-activated Gene (NAG-1)/GDF15, a Protein Associated with Cancer |
| 5/1/2012 | E-021-2011/0 | | Potential Chemotherapeutic Agents: Synthetic Peptide Inhibitors of the Wnt Pathway |
| 4/30/2012 | E-097-2012/0 | | Mouse Monoclonal Antibody Targeting Human NOX1, a Target for Cancer and Inflammation |
| 4/30/2012 | E-233-2011/0 | | Cell Line for Producing Furin That Can Cleave Papillomavirus L2, Toxins and Other Substrates |
| 4/19/2012 | E-036-2008/0 | | Monoclonal Antibodies Targeting Human DNA Polymerase beta, a DNA Repair Enzyme |
| 4/19/2012 | E-111-2012/0 | | Stat1LoxP (Stat1tm1Mam) Mouse Model for Oncology and Immunology Studies |
| 4/19/2012 | E-113-2012/0 | | Tg(MMTV-Cre)#Mam Mouse Model for Developmental Biology, Hepatology, and Oncology Studies |
| 4/19/2012 | E-118-2012/0 | | UTX LoxP Mouse Model for Oncology Research |
| 4/19/2012 | E-120-2012/0 | | Sirt1 Knockout (Sirt1tm1.1Cxd) Mouse Model for Oncology and Metabolism Studies |
| 3/29/2012 | E-011-1998/0 | 6,849,417
7,442,543
7,776,607 | Mammalian Selenoprotein Differentially Expressed in Tumor Cells |
| 3/23/2012 | E-267-2010/0 | | T Lymphocyte (T cell) Clones that Recognize the Tumor Associated Antigens gp100 and MART-1 |
| 3/20/2012 | E-215-2011/0 | | The Cancer Stem Cell Finder: A Novel Reporter Construct which uses Transposition and Green Fluorescent Protein Expression to identify Cancer Stem Cells |
| 2/29/2012 | E-149-2011/0 | | NOX5 Immunogenic Peptides and Monoclonal Antibodies for the Detection of Cancer and Inflammatory Responses |
| 2/22/2012 | E-033-2012/0 | | Model Cell Lines With and Without AKT1 Mutations Derived from Proteus Syndrome Patients |
| 1/18/2012 | E-231-2010/0 | | Transgenic Human Interleukin-21 Mouse Model |
| 1/17/2012 | E-212-2011/0 | | Monospecific and Bispecific Human Monoclonal Antibodies Targeting IGF-II |
| 10/28/2011 | E-266-2011/0 | | New non-HLA-A2 Restricted Human T Cell Receptors (TCRs) that Could be Used to Treat a Broader Cancer Patient Population Via TCR Adoptive Immunity |
| 9/30/2011 | E-094-1994/0 | 7,070,972
7,488,808
7,902,348 | Janus Family Kinases (JAK) And Identification Of Immune Modulators |
| 9/29/2011 | E-123-2010/0 | | mGluR5 Tumor Mouse Model |
| 9/26/2011 | E-302-2009/0 | | Mouse Xenograft Model for Mesothelioma |
| 9/23/2011 | E-068-2011/0 | | Human Monoclonal Antibodies Cross-reacting to Insulin-like Growth Factors IGF-I and IGF-II as Potential Anti-tumor Agents |
| 8/9/2011 | E-173-2010/0 | | Immunocompetent Mouse Model for Tracking Cancer Progression |
| 7/1/2011 | E-175-2011/0 | | Mouse Model and Derived Cells That Hypersecrete Leukemia Inhibitory Factor (LIF) |
| 6/24/2011 | E-296-2010/0 | | Efficient Production of Functional Recombinant Human Neonatal Receptor (FcRn) Proteins |
| 6/14/2011 | E-229-2010/0 | | ERBB4 Mutations Identified in Human Melanoma Metastasis Cell Lines (2690, 2379, 2197, 2183, 2535, 2645, 1770, 2359, 2238, 2319, 2190) |
| 4/19/2011 | E-254-2010/0 | | UOK 268 Cell Line for Hereditary Leiomyomatosis and Renal Cell Carcinoma |
| 4/14/2011 | E-093-2011/0 | | NAG-1 Transgenic Mouse Model |
| 4/12/2011 | E-281-2007/0
E-281-2007/1 | | Three-Dimensional Co-Culture Assay System for Angiogenesis and Metastasis |
| 4/4/2011 | E-234-2010/1 | | Diagnostic and Prognostic Serum Biomarkers for Cancer Patients Treated with Cancer Vaccines |
| 3/23/2011 | E-158-2010/0 | | Agonistic Human Monoclonal Antibodies Against DR4 |
| 2/28/2011 | E-236-2010/0 | | Versatile Melanoma Antigen Family A3 (MAGE-A3) Specific Human T Cell Receptors to Treat Cancer that also Recognize Other MAGE-A Antigen Superfamily Members |
| 1/24/2011 | E-131-2010/0 | | The First Birt-Hogg-Dubé Tumor Cell Line and Wild Type Folliculin-restored Renal Cell Line as In Vitro and In Vivo Models |
| 1/20/2011 | E-091-2008/0 | | Method for Detection and Quantification of PLK1 Expression and Activity |
| 1/5/2011 | E-128-2009/0 | | GATA-3 Reporter Plasmids for Revealing Underlying Mechanisms in Breast Cancer |
| 11/26/2010 | E-272-2010/0 | | Mouse Monoclonal Antibody for CEACAM |
| 11/26/2010 | E-232-2010/0 | | Isocitrate Dehydrogenase 1 (IDH1) R132 Mutation Human Melanoma Metastasis Cell Line |
| 11/9/2010 | E-100-2008/0 | | Cell Line PE, Developed From Mouse Skin Tumors, Demonstrates Unique Qualities |
| 10/21/2010 | E-208-2009/0 | | Mouse Model of Thyroid Cancer |
| 10/12/2010 | E-067-2010/0 | | Inverse Agonists of the TSH Receptor for the Treatment of Thyroid Cancer and Hyperthyroidism |
| 10/12/2010 | E-198-2009/0 | | Mouse Anti-Mouse CXCL9 (Mig) Monoclonal Antibodies |
| 10/8/2010 | E-220-2008/0
E-220-2008/1
E-220-2008/2
E-221-2008/0
E-221-2008/1
E-221-2008/2
E-222-2008/0
E-242-2008/0
E-243-2008/0
E-244-2008/0
E-245-2008/0
E-245-2008/1
E-252-2008/0 | | Antibodies and Antisera Recognizing Members of the ArfGap Family of Protein |
| 9/20/2010 | E-119-2009/0 | | A New “Destination” for Protein Expression: A Lentiviral Gateway® Destination Vector for High-Level Protein Expression (pDEST-673) |
| 9/9/2010 | E-198-2010/0 | | Assay for Arf GTP-binding Proteins |
| 9/9/2010 | E-221-2009/0 | | Chemical Attraction: Cell Lines Expressing the CXCR1 or CXCR2 Chemokine Receptors |
| 8/31/2010 | E-155-2010/0 | | An XMRV Tool Box: Expression Plasmids, Genes, and Proteins for All Components of the Xenotropic Murine Leukemia Virus-Related Virus (XMRV) |
| 8/23/2010 | E-055-2009/0 | | Method of Producing Immortalized Primary Human Keratinocytes for HPV Investigation, Testing of Therapeutics, and Skin Graft Generation |
| 8/17/2010 | E-016-2010/0 | | Transforming Growth Factor Beta-1 (TGF-beta1) Transgenic Mouse Model |
| 8/3/2010 | E-106-2010/0 | | Software for Accurate Segmentation of Cell Nuclei in Breast Tissue |
| 8/3/2010 | E-287-1987/0 | | Immortalized Human Bronchial Epithelial Cell Line |
| 7/12/2010 | E-033-2010/0 | | UOK171, A Spontaneous Clear Cell Type Renal Cell Carcinoma (ccRCC) Human Cell Line Derived from a Surgically Removed Tumor |
| 7/12/2010 | E-191-2010/0 | | A Transgenic Model of Human Basal Triple Negative Breast Cancer [C3(l)-tag mice] |
| 7/7/2010 | E-070-2010/0 | | 888-mel: A Target for Anti-Tumor Immune Responses |
| 6/16/2010 | E-241-2005/0 | | Transgenic Mice in which the Gene for MCP-1 is Deleted |
| 6/16/2010 | E-095-2000/2 | | Amelioration of Inflammatory Arthritis Targeting the Pre-ligand Assembly Domain (PLAD) of Tumor Necrosis Factor Receptors |
| 6/16/2010 | E-264-2001/0 | H002056 | A Mouse Model of von Hippel-Lindau Disease |
| 6/14/2010 | E-135-2004/0 | | Retinal Pigment Epithelial Cells Immortalized with TERT and Expressing the Adenoviral E1A Oncoprotein |
| 6/14/2010 | E-191-2002/0 | 7,205,334
7,521,475
8,278,348 | Chondropsin-Class Antitumor V-ATPase Inhibitor Compounds, Compositions and Methods of Use Thereof |
| 6/10/2010 | E-040-1993/0 | 5,833,986
5,863,739 | Neutralizing Monoclonal Antibody To Human Alpha PDGF Receptors |
| 6/10/2010 | E-014-2007/0 | 8,198,402 | Peptide and Peptidomimetic Inhibitors of Smoothened Protein as Anti-neoplastic Agents |
| 6/7/2010 | E-009-2010/0 | | BODIPY®-FL Nilotinib (Tasigna®) for Use in Cancer Research |
| 6/7/2010 | E-089-2010/0 | | Spontaneously Transformed Mouse Epithelial Cancer Cell Lines Serving as Mouse Models: A New Model for Cancer Research |
| 6/7/2010 | E-331-2008/0
E-331-2008/1 | | Fully-human Monoclonal Antibodies Against Human EphrinB2 and EphB4 for Use in the Study of Cancer Pathogenesis |
| 6/3/2010 | E-216-1994/0 | 6,057,346 | Inhibition of Retroviral LTR Promoters by Calcium Response Modifiers |
| 4/12/2010 | E-059-2010/0 | | Tumor Tissues Harboring Mutations in cAMP-specific Phosphodiesterases Useful for the Study of Endocrine Tumors |
| 3/15/2010 | E-048-2003/0 | | A Mouse Model for Conditional Gene Deletion of c-Met Receptor |
| 3/11/2010 | E-245-2002/0 | 7,378,403 | Prevention and Treatment of Cancer with Kinase Inhibitors Targeting the PH Domain of AKT |
| 3/1/2010 | E-058-2010/0 | | Patient-derived Gastrointestinal Stromal and Paraganglioma Tumor Samples Harboring Novel Stem Cell Factor FOXD3 Variants |
| 1/22/2010 | E-295-2001/0 | | Imaging of Extracellular Proteases in Cells Using Mutant Anthrax Toxin Protective Antigens |
| 12/2/2009 | E-005-2010/0 | | Human Renal Cell Carcinoma (RCC) Cell Lines Derived from Surgically Removed Tumors |
| 12/1/2009 | E-146-2007/1 | | Selenocysteine Mediated Hybrid Antibody Molecules |
| 10/12/2009 | E-345-2008/0 | | CXCR4 and CCR10 Expressing Cells: Useful for the Study of Cancer Cell Survival and Metastasis |
| 8/11/2009 | E-058-2009/0 | | Development of a New Carbohydrate Antibody to GalNac1-3Gal |
| 7/29/2009 | E-229-2009/0 | | A Tumorigenic MEF/3T3 Tet-Off Mouse Fibroblast Cell Line Stably Transfected with a T7-Tagged Srp20 Expression Construct (pJR17) |
| 6/11/2009 | E-164-2007/0 | | Compounds Binding to the N-Terminal Domains of STAT Proteins as Therapeutic Agents |
| 6/8/2009 | E-171-2009/0 | | Improved Antibodies Against ErbB4/Her4 |
| 5/28/2009 | E-101-2006/0 | | Tools to Identify Candidates for Effective Cancer Therapy: Antibodies to Human Asparagine Synthetase |
| 5/28/2009 | E-162-2004/0 | | Mouse Model with Targeted Disruption of the Neurofibromatosis Type-1 (Nf1) Gene |
| 5/15/2009 | E-129-2009/0 | | A549 Cells: A Well-Characterized Lung Carcinoma Cell Line Utilized for a Variety of Scientific Studies, including Adenovirus Production and Testing |
| 5/4/2009 | E-154-2004/0 | | Creation and Characterization of Carcinogen-Altered Mouse Epidermal Cell Lines |
| 5/4/2009 | E-159-2005/0 | | DU145 Camptothecin (CPT)-Resistant Cell Line |
| 5/4/2009 | E-053-2006/0 | | Polyclonal Antibody Against Bloom's Syndrome Protein (BLM) for Research and Diagnostic Use |
| 5/4/2009 | E-193-1997/0 | 6,555,367 | Targeted Recombinant Adenoviral Vectors |
| 2/25/2009 | E-245-2003/0 | | Glutathione S-transferase Clones for Members of the Ubiquitin-Dependent Protein Degradation Pathway |
| 12/1/2008 | E-003-2008/0 | | A Novel, Non-Invasive and Therapeutically Useful High Throughput Technique to Isolate Highly Enriched Tumor Reactive Lymphocytes from Peripheral Blood - Potential Use in Adoptive Immunotherapy |
| 11/1/2008 | E-174-2008/0 | | Therapeutic Targeting of CSN5, a Negative Regulator of p53 and p27, in Human Hepatocellular Carcinoma |
| 5/1/2008 | E-080-2008/0 | | Human and Improved Murine Monoclonal Antibodies Against CD22 |
| 5/1/2008 | E-079-2008/0 | 8357783 | Human Monoclonal Antibody Against Mesothelin |
| 5/1/2008 | E-316-2007/0 | | Method of Inhibiting ABCG2 and Related Treatments |
| 2/1/2008 | E-186-2007/2 | | Papilloma Pseudovirus for Detection and Therapy of Tumors |
| 9/1/2007 | E-272-1998/0 | 6,790,948
7,431,926
7,919,590
8,206,937 | Tumor Suppressor Genes |
| 9/1/2007 | E-153-1998/0 | 7,256,256 | Peptide Inhibitor of Cyclin Dependent Kinase 4 (CDK4) Derived from MyoD |
| 8/1/2007 | E-068-1998/0 | 6,685,933
7,235,232 | Interferon Alpha Hybrids |
| 5/1/2007 | E-281-2002/0 | 7,193,053 | Leu574 of HIF-1alpha as a Molecular Basis for Therapeutic Application |
| 5/1/2007 | E-307-2004/1 | | Aminoalkyl Substituted O6-Benzylguanine Derivatives as Inactivators of O6-Alkylguanine-DNA Alkyltransferase and Adjuvants for Chemotherapy |
| 1/1/2007 | E-293-2006/0 | | Megakaryocyte Potentiation Factor as a New Serum Tumor Marker for Mesothelioma |
| 12/1/2006 | E-330-2003/0 | | Antisera to Detect Phosphorylated Phosphoinositide-Dependent Kinase 1 (PDK-1) |
| 6/1/2006 | E-336-2005/0 | 8,071,323 | Novel Human IGF-1 Specific IGF-I and IGF-II Cross-Reactive Human Monoclonal Antibodies as Potential Anti-tumor Agents |
| 3/1/2006 | E-262-1999/1 | 7,459,536 | Monoclonal Antibodies Which Specifically Bind to the Ligand Hepatocyte Growth Factor (HGF) and are Useful in the Treatment of Cancer |
| 12/1/2005 | E-323-2003/0 | 7,589,181
7,915,396 | Minimally Immunogenic Variants of SDR-Grafted Humanized Antibody CC49 and Their Use |
| 12/1/2005 | E-264-2005/0 | | Mouse Polyclonal Antibodies to KAI1 |
| 10/1/2005 | E-327-2005/0 | | NIH3T3 Cell Lines Carrying c-Met Mutations Including G3906A, G3522A, G3810T, T3936C, T3936G, T3997C, C3528T, C3564G, C3831G, A3529T, and T3640C |
| 10/1/2005 | E-274-2005/0 | | Murine Mast Cell Line Useful for Toxicity and Immunopotency Screens |
| 10/1/2005 | E-167-1997/0 | 7,153,866 | The Use of Nitroxides in the Prophylactic and Therapeutic Treatment of Cancer Due to Genetic Defects |
| 9/1/2005 | E-327-2004/0 | | A New Approach Toward Macrocyclization of Peptides |
| 9/1/2005 | E-144-2005/0 | | Soluble Fragments of the IGF1R Ectodomain |
| 9/1/2005 | E-087-1996/0 | | Heterologous Boosting Immunizations |
| 8/1/2005 | E-168-2005/0 | | Monoclonal Antibody to the Protein NCOA6 (also called ASC-2, AIB-3) |
| 6/1/2005 | E-339-2004/0 | 7,855,276 | Framework Residue Substituted Humanized COL-1 Antibodies and Their Use |
| 5/1/2005 | E-351-2004/0 | | Antibodies to Rheb, a Ras-Related Protein |
| 5/1/2005 | E-245-2004/0 | | Methods of Reducing the Activity and Concentration of an Eph Receptor Tyrosine Kinase |
| 4/1/2005 | E-265-1994/0
E-265-1994/1 | | Nucleotide and Deduced Amino Acid Sequences of a New Tumor Gene, Int6 |
| 4/1/2005 | E-324-2001/2 | 8,283,122 | Selections of Genes and Methods of Using the Same for Diagnosis and for Targeting the Therapy of Select Cancers |
| 4/1/2005 | E-156-2004/0 | | Chinese Hamster Ovary Cells Resistant to Colcemid with Altered beta-Tubulin |
| 3/1/2005 | E-105-2004/0
E-105-2004/1 | | Minimally Immunogenic Germline Sequence Variants of COL-1 Antibody and Their Use |
| 3/1/2005 | E-166-2001/0 | 7,557,196 | HGC-1, A Gene Encoding a Member of the Olfactomedin-Related Protein Family |
| 3/1/2005 | E-108-2004/0
E-234-2003/0 | 7,711,492 | Methods for Identifying, Diagnosing, and Predicting Survival of Lymphomas |
| 1/1/2005 | E-017-2005/0 | | Methods and Composition for Development of Preclinical Testing of Anticancer Therapies Using Transgenic Animals |
| 1/1/2005 | E-123-2001/0
E-124-2001/1 | 7,247,615 | Peptide Agonists of Prostate-Specific Antigen and Uses Thereof |
| 9/1/2004 | E-243-2004/0 | | Vectors for Wild-Type DDR1b or DDR1b Mutant, and Production of THP-1 Cell Line Expressing Two DDR1 Isoforms, DDR1a and DDR1b |
| 8/1/2004 | E-266-2004/0 | | Mouse Model of PRKAR1A Down-Regulation |
| 6/1/2004 | E-112-1994/0 | 5,652,223
5,981,712
6,790,936 | DNA Encoding CAI Resistance Proteins and Uses Thereof |
| 5/1/2004 | E-131-2004/0 | | AT8, a Hybridoma Cell Line Producing a Monoclonal Antibody (MAb) Specific for Ly49G, a Mouse Natural Killer (NK) Cell Receptor |
| 3/1/2004 | E-107-2004/0 | | Specific Antibodies to the Lymphatic Endothelial Cell Specific Hyaluronic Acid Receptor, LYVE-1 |
| 11/1/2003 | E-008-2001/0 | 7,598,077 | Compositions and Methods for Enhancing Differential Gene Expression |
| 6/1/2003 | E-091-2002/0 | 7,329,502
7,981,610 | Zap70 Protein Expression as a Marker for Chronic Lymphocytic Leukemia (CLL) |
| 5/1/2003 | E-161-2003/0 | | Flp-in T-Rex Jurkat Cell Line |
| 2/1/2003 | E-340-2002/0 | | 4G10, a Monoclonal Antibody Against the Chemokine Receptor CXCR4, Raised Against a Synthetic Peptide of 38 Residues in Length Derived from the N-terminal Sequence of CXCR4 |
| 4/1/2002 | E-099-2001/0 | | Mitochondrial Topoisomerase I |
| 11/1/2001 | E-261-1998/0 | 6,969,614 | Methods and Devices for Isolation and Analysis of Cellular Protein Content |
| 5/1/2001 | E-203-1994/0 | 5,693,779 | Production and Use of Anti-Dorsalizing Morphogenetic Protein |
| 4/1/2001 | E-149-2000/0 | 6,756,215 | Biologically Active FLAG-Epitope-Tagged Transforming Growth Factor Beta (TGF-beta) Protein |
| 3/1/2001 | E-336-1987/1 | 5,693,778 | ARG, A Human Gene Related to but Distinct from ABL Proto-Oncogene |
| 12/1/2000 | E-014-2000/0 | 6,600,018
7,223,853
7,947,651
8,158,603 | Secreted Frizzled Related Protein, sFRP, Fragments and Methods of Use Thereof |
| 9/1/2000 | E-142-1999/0 | 6,362,317
6,884,873 | Anti-H2A Antibody and Method for Detecting DNA Double-Stranded Breaks |
| 7/1/1999 | E-077-1999/0 | 6,623,960
7,524,939 | Monoclonal Antibodies Specific And Inhibitory To Human Cytochrome P450 2C8, 2C9, 2C18 And 2C19 - New Avenues For Drug Discovery |
| 6/1/1999 | E-032-1995/0 | 5,650,627 | Sensitive Assay for Measuring Gallium Levels in Body Tissues and Fluids |
| 4/1/1999 | E-157-1994/1 | 6,787,306
7,402,387 | Method and Composition for Detecting Dihydropyrimidine Dehydrogenase Splicing Mutations |
| 3/1/1999 | E-071-1991/2 | 5,645,988 | Method of Identifying and Using Drugs with Selective Effect Against Cancer Cells |
| 10/1/1998 | E-150-1998/0 | 6,323,325 | Agents That Bind To And Inhibit Cytochrome P450 2A6 |
| 10/1/1998 | E-122-1998/0 | 6,335,428 | Agents That Bind To And Inhibit Human Cytochrome P450 1A2 |
| 10/1/1997 | E-246-1988/0 | | Laminin A Peptides |
| 5/1/1997 | E-046-1997/0 | 6,060,253 | Agents That Bind To And Inhibit Human Cytochrome P450 2D6 |
| 1/1/1997 | E-160-1992/1 | 5,717,067 | eps15, Substrate For The Epidermal Growth Factor Receptor Kinase |
| 11/1/1996 | E-185-1995/0 | 5,939,530 | Inhibitory And Non-Inhibitory Antigen Binding Polypeptides Against Human P450 Enzymes |
| 7/1/1996 | E-221-1989/0
E-221-1989/1 | 5,820,859
5,916,755 | Novel Epidermal Growth Factor Receptor (ErbB-3) And Antibodies |
| 4/1/1996 | E-029-1990/0
E-029-1990/1 | 5,702,907
5,811,262 | Hepatocellular Carcinoma Oncogene |
| 11/1/1994 | E-005-1993/0 | 5,532,348 | E6-Associated Protein And Methods Of Use |
| 4/1/1994 | E-116-1992/0 | 5,569,602 | The First Immortalized Kaposi's Sarcoma Cell Line |
| 1/1/1994 | E-253-1993/0 | 5,709,996
5,716,620
5,744,142
5,756,284
5,871,998
5,985,610 | Self-Assembling Recombinant Papillomavirus Capsid Proteins |
| 2/1/1992 | E-193-1990/0 | | Molecular Encapsulation and Delivery of Alkanes to Living Mammalian Cells for Risk Assessment and Pharmaceutical Applications |